Yong Zang

  • 152 Citations
  • 6 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yong Zang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Clinical Trials Mathematics
Biomarkers Mathematics
Phase II Clinical Trials Medicine & Life Sciences
Case-control Mathematics
Genetic Models Medicine & Life Sciences
Robust Tests Mathematics
Genetic Association Mathematics
Misclassification Mathematics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2008 2019

  • 152 Citations
  • 6 h-Index
  • 22 Article
  • 1 Letter
  • 1 Review article

A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling

Zang, Y., Guo, B., Han, Y., Cao, S. & Zhang, C., Jan 1 2019, In : Statistics in Medicine.

Research output: Contribution to journalArticle

Hierarchical Modeling
Biomarkers
Treatment Effects
Subgroup
Therapeutics

Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial

Fulton, C. R., Zang, Y., Desta, Z., Rosenman, M., Holmes, A., Decker, B., Zhang, Y., T Callaghan, J., Pratt, V. M., Levy, K., Gufford, B. T., Dexter, P., Skaar, T. & Eadon, M., Apr 1 2019, In : Pharmacogenomics. 20, 6, p. 397-408 12 p.

Research output: Contribution to journalArticle

Tramadol
Codeine
Drug Interactions
Cytochrome P-450 CYP2D6
Pharmaceutical Preparations

Robust tests for gene–environment interaction in case-control and case-only designs

Zang, Y., Fung, W. K., Cao, S., Ng, H. K. T. & Zhang, C., Jan 1 2019, In : Computational Statistics and Data Analysis. 129, p. 79-92 14 p.

Research output: Contribution to journalArticle

Gene-environment Interaction
Robust Tests
Case-control
Type I Error Rate
Specifications

A Bayesian adaptive phase II clinical trial design accounting for spatial variation

Guo, B. & Zang, Y., Jan 1 2018, (Accepted/In press) In : Statistical Methods in Medical Research.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Clinical Trials
Efficacy
Treatment Effects
Covariates
1 Citation (Scopus)

An in vivo screen identifies PYGO2 as a driver for metastatic prostate cancer

Lu, X., Pan, X., Wu, C. J., Zhao, D., Feng, S., Zang, Y., Lee, R., Khadka, S., Amin, S. B., Jin, E. J., Shang, X., Deng, P., Luo, Y., Morgenlander, W. R., Weinrich, J., Lu, X., Jiang, S., Chang, Q., Navone, N. M., Troncoso, P. & 2 others, DePinho, R. A. & Wang, Y. A., Jul 15 2018, In : Cancer Research. 78, 14, p. 3823-3833 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Oncogenes
Neoplasm Metastasis
Biomarkers
Lymph Nodes